Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study
Licitra, L., Mesia, R., Rivera, F., Remenár, É., Hitt, R., Erfán, J., Rottey, S., Kawecki, A., Zabolotnyy, D., Benasso, M., Störkel, S., Senger, S., Stroh, C., Vermorken, J.B.
Published in Annals of oncology (01.05.2011)
Published in Annals of oncology (01.05.2011)
Get full text
Journal Article
Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial
Hitre, E, Budai, B, Takácsi-Nagy, Z, Rubovszky, G, Tóth, E, Remenár, É, Polgár, C, Láng, I
Published in British journal of cancer (03.09.2013)
Published in British journal of cancer (03.09.2013)
Get full text
Journal Article
OC-021: Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN
Soulières, D, Faivre, S, Mesía, R, Remenár, E, Li, S.H, Karpenko, A, Dechaphunkul, A, Keilholz, U, Kiss, L, Lin, J.C, Nagarkar, R, Tamás, L, Kim, S.B, Erfán, J, Alyasova, A, Yovine, A, Le Mouhaër, S, Solovieff, N, Turri, S, Licitra, L
Published in Radiotherapy and oncology (01.03.2017)
Published in Radiotherapy and oncology (01.03.2017)
Get full text
Journal Article
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study
Psyrri, A., Fortpied, C., Koutsodontis, G., Avgeris, M., Kroupis, C., Goutas, N., Menis, J., Herman, L., Giurgea, L., Remenár, É., Degardin, M., Pateras, I.S., Langendijk, J.A., van Herpen, C.M.L., Awada, A., Germà-Lluch, J.R., Kienzer, H.R., Licitra, L., Vermorken, J.B.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
Vermorken, J.B., Peyrade, F., Krauss, J., Mesía, R., Remenar, E., Gauler, T.C., Keilholz, U., Delord, J.P., Schafhausen, P., Erfán, J., Brümmendorf, T.H., Iglesias, L., Bethe, U., Hicking, C., Clement, P.M.
Published in Annals of oncology (01.03.2014)
Published in Annals of oncology (01.03.2014)
Get full text
Journal Article
TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial
Specenier, P.M., Remenar, E., Buter, J., Schrijvers, D.L., Bergamini, C., Licitra, L.F., Awada, A., Clement, P.M., Fortpied, C., Menis, J., Vermorken, J.B.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971 TAX 323)
van Herpen, C M L, Mauer, M E, Mesia, R, Degardin, M, Jelic, S, Coens, C, Betka, J, Bernier, J, Remenar, E, Stewart, J S, Preiss, J H, van den Weyngaert, D, Bottomley, A, Vermorken, J B
Published in British journal of cancer (12.10.2010)
Published in British journal of cancer (12.10.2010)
Get full text
Journal Article
8533 POSTER First Results of an Uncontrolled, Phase II Trial of Induction Chemotherapy With Cetuximab and Docetaxel-Cisplatin-5FU Followed by Cetuximab+Radiotherapy in the Responders in Locally Advanced Resectable Squamous Cell Cancer of the Head and Neck
Remenar, E, Lövey, J, Koltai, P, Horvath, K, Gödeny, M, Kasler, M
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Model screening for oral cavity and pharyngeal cancer in Hungary
Koltai, P., Remenár, É., Fülöp, M., Oberna, F., Pólus, K.
Published in European journal of cancer (1990) (01.04.2001)
Published in European journal of cancer (1990) (01.04.2001)
Get full text
Journal Article
Low-dose paclitaxel radiosensitization in locally advanced head and neck cancers
Lövey, J., Koronczay, K., Remenár, É., Csuka, O., Németh, G.
Published in European journal of cancer (1990) (01.04.2001)
Published in European journal of cancer (1990) (01.04.2001)
Get full text
Journal Article
The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical Trial
Tímár, József, Forster-Horváth, C, Lukits, J, Döme, B, Ladányi, A, Remenár, E, Kásler, M, Bencsik, M, Répássy, G, Szabó, G, Velich, N, Suba, Z, Elõ, J, Balatoni, Z, Bajtai, A, Chretien, P, Talor, Eyal
Published in The Laryngoscope (01.12.2003)
Published in The Laryngoscope (01.12.2003)
Get more information
Journal Article
819 Significance of p53 and bcl2 levels in the radio-sensitivity of head and neck cancer
Csuka, O., Németh, G., Koronczay, K., Doleschall, Z., Remenár, É.
Published in European journal of cancer (1990) (01.11.1995)
Published in European journal of cancer (1990) (01.11.1995)
Get full text
Journal Article
Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head andneck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971)
Vermorken, J. B., Remenar, E., van Herpen, C., Germa Lluch, J., Stewart, S., Gorlia, T., Degardin, M., Schollen, K., Bernier, J.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head andneck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971)
Vermorken, J. B., Remenar, E., van Herpen, C., Germa Lluch, J., Stewart, S., Gorlia, T., Degardin, M., Schollen, K., Bernier, J.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
5548 POSTER Circulating hormone levels and prognosis in head and neck cancer
Remenar, E, Vincze, B, Szamel, I, Ladanyi, A, Timar, J, Kasler, M
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease
Harrington, Kevin, Berrier, Alain, Robinson, Martin, Remenar, Eva, Housset, Martin, de Mendoza, Fernando Hurtado, Fayette, Jérôme, Mehanna, Hisham, El-Hariry, Iman, Compton, Natalie, Franklin, Natalie, Biswas-Baldwin, Nigel, Lau, Mike, Legenne, Philippe, Kumar, Rejnish
Published in European journal of cancer (1990) (01.05.2013)
Published in European journal of cancer (1990) (01.05.2013)
Get full text
Journal Article